Does contraversive circling in the 6-OHDA-lesioned rat indicate an ability to induce motor complications as well as therapeutic effects in Parkinson's disease?

被引:49
作者
Lane, EL
Cheetham, SC
Jenner, P
机构
[1] Kings Coll London, GKT, Sch Biomed Sci, Neurodegenerat Dis Res Ctr, London WC2R 2LS, England
[2] RenaSci Consultancy Ltd, Nottingham, England
基金
英国生物技术与生命科学研究理事会;
关键词
monoannine reuptake inhibitor; Parkinson's disease; L-dopa; behaviour;
D O I
10.1016/j.expneurol.2005.06.006
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Circling behaviour in unilateral 6-OHDA-lesioned rats is interpreted as being opposite in direction to the side of the brain with highest striatal dopaminergic activation. Ipsiversive rotation indicates an action on the intact striatum, while contraversive rotation demonstrates an effect on dopamine receptors in the denervated striatum and is taken as predictive of symptomatic benefit in Parkinson's disease. But does an equivalent behavioural outcome result from stimulating the intact and denervated striatum to the same degree? We report on the behavioural responses produced by administration of L-dopa and the monoamine uptake inhibitor BTS 74 398. These were given alone, or in combination, at doses equivalent to their ED25, ED50 and ED75 for inducing circling in unilateral 6-OHDA-lesioned rats. L-dopa administered alone induced dose-dependent contraversive circling while BTS 74 398 produced ipsiversive rotation. However, L-dopa and BTS 74 398 in combination, produced the same contraversive circling response as when L-dopa was administered alone. Little or no ipsiversive rotation occurred, irrespective of the combination of doses employed. This surprising finding suggests that there are major differences in the outcome of stimulating the intact and denervated striatum with the latter dominating the behavioural response. Since repeated administration Of L-dopa but not BTS 74 398, sensitises rotational responses and induces abnormal movements, it may be that contraversive rotation is predictive of both clinical response in PD and the ability to induce motor complications. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:284 / 290
页数:7
相关论文
共 31 条
[1]   EFFECTS OF L-DOPA ON EXTRACELLULAR DOPAMINE IN STRIATUM OF NORMAL AND 6-HYDROXYDOPAMINE-TREATED RATS [J].
ABERCROMBIE, ED ;
BONATZ, AE ;
ZIGMOND, MJ .
BRAIN RESEARCH, 1990, 525 (01) :36-44
[2]  
ASIN KE, 1995, J PHARMACOL EXP THER, V273, P1483
[3]  
BARAJIMENEZ W, 2005, MOVEMENT DISORD, V19, P1183
[4]   Methylphenidate increases the motor effects of L-dopa in Parkinson's disease: A pilot study [J].
Camicioli, R ;
Lea, E ;
Nutt, JG ;
Sexton, G ;
Oken, BS .
CLINICAL NEUROPHARMACOLOGY, 2001, 24 (04) :208-213
[5]   CHRONIC L-DOPA TREATMENT IN THE UNILATERAL 6-OHDA RAT - EVIDENCE FOR BEHAVIORAL SENSITIZATION AND BIOCHEMICAL TOLERANCE [J].
CAREY, RJ .
BRAIN RESEARCH, 1991, 568 (1-2) :205-214
[6]   RELATIONSHIP OF CHANGES IN SPONTANEOUS MOTOR-ACTIVITY TO SPONTANEOUS CIRCLING IN RATS WITH UNILATERAL 6-HYDROXYDOPAMINE LESIONS OF THE SUBSTANTIA-NIGRA [J].
CAREY, RJ .
EXPERIMENTAL NEUROLOGY, 1986, 92 (03) :591-600
[7]   L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA [J].
Cenci, MA ;
Lee, CS ;
Björklund, A .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1998, 10 (08) :2694-2706
[8]   NONSPECIFIC SUPERSENSITIVITY OF STRIATAL DOPAMINE RECEPTORS AFTER 6-HYDROXYDOPAMINE LESION OF NIGROSTRIATAL PATHWAY [J].
COSTALL, B ;
NAYLOR, RJ ;
PYCOCK, C .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1976, 35 (02) :275-283
[9]   NOMIFENSINE - POTENT DOPAMINERGIC AGONIST OF ANTIPARKINSON POTENTIAL [J].
COSTALL, B ;
KELLY, DM ;
NAYLOR, RJ .
PSYCHOPHARMACOLOGIA, 1975, 41 (02) :153-164
[10]   PERGOLIDE-INDUCED CIRCLING IN RATS WITH 6-HYDROXYDOPAMINE LESIONS IN THE NIGROSTRIATAL PATHWAY [J].
DUVOISIN, RC ;
HEIKKILA, RE ;
MANZINO, L .
NEUROLOGY, 1982, 32 (12) :1387-1391